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Merkel cell carcinoma is a rare and aggressive neuroendocrine-derived skin cancer arising most commonly on the
sun-exposed head and neck skin of elderly and immunocompromised patients. Although a combination of wide excision
and adjuvant radiotherapy is the optimal therapeutic approach for Merkel cell carcinoma, radiation monotherapy
has recently been recommended for unresectable tumors. We report here a case of Merkel cell carcinoma treated
with radiation monotherapy and reviewed Merkel cell carcinoma cases treated with radiotherapy alone in Japan.
A 75-year-old man was referred for treatment of a tumor on the upper lip with a swollen submental lymph node.
The histopathological diagnosis from biopsied material was Merkel cell carcinoma (T3N1bM0, stage IIIB). The submental
lymph node was extirpated and radiation monotherapy was applied according to the 2014 National Comprehensive
Cancer Network Guidelines because the Eastern Cooperative Oncology Group Performance Status of the patient was
grade 3 and the patient and his family did not desire surgery. The primary site and bilateral upper neck regions were
irradiated with 45 Gy followed by 20 Gy irradiation for the primary site alone. Three months after radiotherapy, the
tumor seemed to have completely remitted. Approximately 1 year after radiotherapy, no evidence of local recurrence
or late metastasis has been noted. Radiation monotherapy should be considered as a curative treatment for Merkel cell
carcinoma, particularly in situations where extensive surgery is not favored.
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Merkel cells are afferent sensory receptors that function
as mechanoreceptors in the basal layer of the epidermis
[1]. Merkel cell carcinoma (MCC) was first described in
1972 by Toker [2] and represents a rare and aggressive
neuroendocrine-derived skin cancer that arises most
commonly on the sun-exposed head and neck skin of
elderly and immunocompromised patients. It has been
debated whether MCC arises from malignant transform-
ation of a Merkel cell [3] or from a pluripotent stem cell
[4]. This malignancy shows a strong tendency for lymph
node metastasis, distant metastasis, and recurrence, which
are associated with poor prognosis. The 2014 National
Comprehensive Cancer Network Guidelines [5] advocate* Correspondence: nkitamura@kochi-u.ac.jp
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and adjuvant radiotherapy, but definitive radiation mono-
therapy has recently been recommended for unresectable
tumors, as MCC appears highly sensitive to radiotherapy
[6-9]. We present here the case of a patient who achieved
complete remission of MCC on the upper lip with neck
lymph node metastasis using radiotherapy alone and review
MCC cases treated with radiation monotherapy in Japan.Case presentation
A 75-year-old man was referred for treatment of a 5 × 4-cm
reddish nodule on the upper lip and a 2 × 2-cm lymph node
in the submental region in December 2013 (Figure 1A,B).
The medical past history of the patient was prostate cancer,
cerebral infarction, and diabetes mellitus. Histopathological
examination of the lip tumor revealed an aggregation of
atypical tumor cells with scant cytoplasm and immunohis-
tochemical positivity for CK20, AE1/AE3, synaptophysin,al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 First medical examination. (A) Anterior face view. (B) Neck view. (C,D) Computed tomography of the head and neck region. (E,F,G)
PET-CT of the whole body and head and neck region.
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Computed tomography indicated approximately 4 × 3-cm
and 2 × 2-cm enhanced masses in the upper lip and sub-
mental region, respectively (Figure 1C,D). Hot spots of
18fluorodeoxyglucose on positron emission tomographyFigure 2 Immunohistochemical staining of metastatic MCC (primary specimwere detected at the same sites seen on computed tomog-
raphy (Figure 1E,F,G). The values of SUVmax in the pri-
mary site and submental lymph node were 3.4 and 3.3,
respectively. According to the 2014 National Comprehen-
sive Cancer Network Guidelines [5], the submental lymphen).
Figure 3 Field settings for radiotherapy. The patient received 4-MV linac X-ray, lateral parallel opposed paired ports for primary site and bilateral
levels I and II (45 Gy/25 fr) plus electrons for the primary site alone (20 Gy/10 fr). Field margins were ≥2 cm around the lesion.
Figure 4 Treatment and course.
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Figure 5 Nine months after radiotherapy. (A) Anterior face view. (B) Neck view.
Table 1 Merkel cell carcinoma treated with radiotherapy alone in the past 20 years in Japan
No. Author Year Age/sex Sites Stage Dose Response Recurrence F/U period
H&N Limbs I II III IV (Gy) (months)
1 A. Aoki 1995 90F 1 1 40 SD + 0
2 H. Okada 1995 83F 1 1 30 CR + 9
3 S. Nasu 1997 88F 1 1 38 CR 14
4 K. Murata 1997 89F 1 1 60 CR N/A
5 T. Inoue 1999 96M 1 1 50 CR 4
6 Y. Handa 2000 88M 1 1 51 CR 9
7 H. Ono 2001 78F 1 1 50 CR 9
8 S. Seki 2003 60M 1 1 56 CR 21
9 69F 1 1 60 CR 5
10 N. Narita 2004 96M 1 1 66 CR + 1
11 E. Makino 2005 84F 1 1 48 CR 8
12 T. Nakamura 2005 83F 1 1 60 CR + 2
13 A. Niiya 2006 72F 1 1 60 CR + 24
14 66F 1 1 60 CR 18
15 T. Yamakawa 2008 98F 1 1 36 CR 12
16 R. Maeda 2010 86F 1 1 70 CR 19
17 J. Hujitaka 2011 87M 1 1 54 CR 32
18 K. Hanaoka 2011 90F 1 1 28 CR + 4
19 A. Saito 2012 90F 1 1 45 CR 12
20 80M 1 1 60 CR 22
21 86M 1 1 70 CR + 12
22 Present case 2014 75M 1 1 65 CR 12
19 3 7 11 3 1 52.6 ± 12.2 CR:21, SD:1 7/22 11.0 ± 8.4
CR, complete response; F, female; F/U, follow-up; H&N, head and neck; M, male; NA, data not available; SD, stable disease.
Mean age = 83.4 ± 9.9; 8 males, 14 females.
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of MCC was confirmed. TNM classification was diag-
nosed as T3N1bM0, stage IIIB. Treatment with radi-
ation monotherapy was applied because the Eastern
Cooperative Oncology Group Performance Status of
the patient was grade 3, and the patient and family did
not desire surgery. The primary site and bilateral upper
neck (levels I and II) regions were irradiated with a
dose of 45 Gy/25 fr, followed by irradiation of 20 Gy/10
fr to the primary site alone (Figure 3). Field margins
were generally ≥2 cm around the gross tumor volume.
During the irradiation period, the planned radiation
dose was accomplished using both infusion of electro-
lyte solution and tubal feeding, although the patient
was forced to stop radiation therapy for approximately
10 days due to aspiration pneumonia (Figure 4). At
3 months after radiotherapy, the tumor seemed to show
complete remission. As of approximately 1 year after
radiotherapy, no evidence of local recurrence or late
metastasis has been noted (Figure 5).
Discussion
MCC is a rare, aggressive, neuroendocrine-derived skin
cancer that arises most commonly on the sun-exposed
head and neck skin of elderly and immunocompromised
patients. MCC at all body sites shows an incidence of
around 0.6 per 100,000 capita, but this figure has been
increasing over the past 20 years [10]. This malignancy
shows a high tendency toward lymph node metastasis,
distant metastasis, and recurrence, all of which are pre-
dictive of poor prognosis. The acronym “AEIOU” can
be applied to describe the clinical features of MCC:
asymptomatic/non-tender, expanding rapidly, immune-
suppressed, older than 50 years, and ultraviolet-exposed fair
skin [11,12]. The 2014 National Comprehensive Cancer
Network Guidelines [5] advocate wide local excision (safe
margin, 2 ~ 3 cm) with regional lymph node dissection and
adjuvant radiotherapy.
On the other hand, for unresectable cases, particularly
in patients who would not tolerate wide surgical excision
due to comorbidities, or where significant cosmetic or
functional deficits would be incurred, definitive radiation
monotherapy has recently been recommended, because
MCC is highly sensitive to radiotherapy [6-9]. Pape et al.
found no significant difference in 5-year disease-free and
overall survival rates (approximately 90% each) between
conventional therapy (surgery followed by radiotherapy)
and radiation monotherapy for stage IB to IIB primary
25 MCC patients, respectively [6]. Medina-Franco et al.
reported that the local relapse rate (LRR) was 10.5% when
tumor excision and adjuvant radiotherapy was performed
for 1,024 MCC patients [13]. Koh and Veness reported 1-
year LRR as 12.5% after performing radiation monotherapy
for eight MCC patients [7]. Sundaresan et al. reported that2-year LRR was 15% for 18 MCC patients receiving defini-
tive radiotherapy [8]. Harrington and Kwan studied 179
MCC patients divided into two groups, with 57 receiving
radical radiotherapy and 122 receiving radical surgery [9].
No significant differences in 5-year LRR (approximately
10% in each group) and 5-year nodal relapse rate (20%~
30% in each group) were seen between the groups.
According to the summary of radiation monotherapy
cases reported in Japan, including the present case, that we
were able to assemble from the past 20 years, complete re-
sponse was achieved in 21 of 22 patients (95.5%), and local
relapse/late metastasis was seen in 7 of 22 patients (31.8%)
(Table 1) [14-30]. Only good cases may have been reported
because all Japanese MCC cases were obtained from case
reports. Even so, the results suggest that radiation mono-
therapy in Japan is an effective option, supporting the re-
sults of large-scale studies from other countries [6,10-12].
Furthermore, only three cases of radiation monotherapy for
Japanese MCC stage III have been reported, including the
present case (including two head and neck cases), and the
two cases other than this case both showed recurrence (at
2 and 24 months). Careful follow-up will thus be essential
in the present case.
Conclusions
Radiation monotherapy appears effective for the curative
treatment of MCC and should be used, especially in situa-
tions where extensive surgery is not favored.
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